Jeff Silverman

Jeff Silverman has an extensive work experience spanning several companies and academic institutions. Jeff currently works as a Senior Research Fellow at Edgewise Therapeutics since July 2022. Prior to this, they held various roles at different organizations, including Vice President of Early Development at Jazz Pharmaceuticals from December 2017 to April 2022. Jeff also worked as a Pharmacology Consultant from October 2013 to December 2017. Jeff has held positions such as Director of Clinical Pharmacology at Gilead Sciences from October 2014 to November 2017, and VP of Clinical Pharmacology and Translational Research at Talon Therapeutics from December 2010 to October 2013. Jeff has also served as an Adjunct and Associate Professor at the University of California, San Francisco, in the Departments of Bioengineering & Therapeutic Sciences and Biopharmaceutical Sciences, respectively. Furthermore, they held several senior positions at various pharmaceutical companies, including Senior Director of Pharmacology at Sunesis Pharmaceuticals from February 2002 to August 2008, and Senior Director of Clinical Pharmacology and Translational Research at Hana Biosciences from May 2009 to December 2010. Jeff began their career at AvMax Inc as the Director of Molecular and Cellular Biology from March 1996 to February 2002. Throughout their career, Jeff has made significant contributions in the field of pharmacology and translational research.

Jeff Silverman completed their Bachelor of Science degree in Zoology at Colorado State University from 1976 to 1979. Subsequently, from 1979 to 1984, they pursued their PhD in Experimental Pathology at the University of Pittsburgh School of Medicine.